Mkts

Journey Medical Corporation

NASDAQ: DERM
$3.69-0.21 (-5.38%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
3.653.92
52-week range
3.409.55
Today
Open3.91
Previous close3.69
Volume—
Valuation
Market cap110.08M
P/E ratio—
EPS (TTM)-0.23
Income & risk
Dividend / yield—
Beta1.31
Avg volume195.3K
Discussion

DERM News

Stories mentioning DERM from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue15,92116,06617,02515,00913,13912,62014,62914,855
Cost of Goods Sold6,2184,7902,2375,2856,541
Gross Profit9,7038,34910,3839,3448,314
Operating Expenses
Research & Development287.0039.00218.00842.00913.00
Sales General & Admin10,1099,86312,05411,88210,56910,06011,39610,328
Total Operating Expenses
Operating Income (Loss)(1,492)(443.00)(1,529)(2,876)(3,324)2,234(2,894)(2,927)
Interest Income
Interest Expense
Other Expense
Pretax Income(2,230)(1,247)(2,315)(3,736)(4,073)1,582(2,390)(3,361)
Tax Provision60.00
Net Income (Loss)(2,230)(1,247)(2,315)(3,796)(4,073)1,521(2,390)(3,361)
Earnings Per Share (Basic)(0.08)(0.05)(0.09)(0.16)(0.18)0.07(0.12)(0.17)
Earnings Per Share (Diluted)(0.08)(0.05)(0.09)(0.16)(0.18)0.07(0.12)(0.17)
Weighted Average Shares Outstanding (Basic)27,30524,49824,95923,29122,61120,43120,53819,994
Weighted Average Shares Outstanding (Diluted)27,30524,49824,95923,29122,61120,43120,53819,994

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About DERM

Journey Medical Corporation (NASDAQ: DERM) is a stock listed on the Nasdaq Stock Market under the ticker symbol DERM. It last traded at $3.69 (Nov 18, 2026, 4:00 PM ET), down 5.4% on the day. That gives Journey Medical a market capitalisation of $110.1M.

Over the past 52 weeks DERM has traded between $3.40 and $9.55.

Revenue for the quarter ended Mar 31, 2026 was $15.9M; a net loss of $2.2M. Revenue was up 21.2% from $13.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$15.9M-$2.2M-14.0%
Dec 31, 2025$16.1M-$1.2M-7.8%
Sep 30, 2025$17.0M-$2.3M-13.6%
Jun 30, 2025$15.0M-$3.8M-25.3%

From Journey Medical’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…